Thomas R. Kuhn - 12 Jun 2025 Form 4 Insider Report for Anterix Inc. (ATEX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Jun 2025, 18:28:01 UTC
Prior SEC filing
24 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
s/ Gena L. Ashe, Attorney-in-Fact

Key filing fact

Thomas R. Kuhn filed Form 4 for Anterix Inc. (ATEX) on 16 Jun 2025.

Key facts

  • This page summarizes Thomas R. Kuhn's Form 4 filing for Anterix Inc. (ATEX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Jun 2025, 18:28.

Change

  • Previous filing in this sequence was filed on 24 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001571521 Primary reporting owner

Kuhn Thomas R.

Relationship
Director, Executive Chairman
Address
3 GARRET MOUNTAIN PLAZA SUITE 401, WOODLAND PARK
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Signature date
16 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATEX transaction

Common Stock

Award

Transaction value
$0
Shares
+6,222
Change %
+60%
Price
$0.000000
Shares after
16,594
Date
12 Jun 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock. The RSU vests in full on the earlier of: (i) June 12, 2026, and (ii) the Issuer's next annual stockholder meeting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .